DNOVO BIO
Dnovobio is a developer of a direct reprogramming technology intended to create any cell, tissue, or organ on demand. Its company's platform converts skin into functional brain cells. The company is currently operating in Stealth mode.
DNOVO BIO
Industry:
Biotechnology Health Care Medical
Founded:
2018-01-01
Address:
San Jose, California, United States
Country:
United States
Website Url:
http://www.dnovobio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.7 M USD
Similar Organizations
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Current Employees Featured
Founder
Investors List
Justin Mateen
Justin Mateen investment in Seed Round - dNovo Bio
Felicis Ventures
Felicis Ventures investment in Seed Round - dNovo Bio
Soma Capital
Soma Capital investment in Seed Round - dNovo Bio
Paul Buchheit
Paul Buchheit investment in Seed Round - dNovo Bio
Y Combinator
Y Combinator investment in Seed Round - dNovo Bio
Joey Krug
Joey Krug investment in Seed Round - dNovo Bio
Pioneer Fund
Pioneer Fund investment in Seed Round - dNovo Bio
Ataria
Ataria investment in Seed Round - dNovo Bio
Jason Hodges
Jason Hodges investment in Seed Round - dNovo Bio
Jean Pigozzi
Jean Pigozzi investment in Seed Round - dNovo Bio
Official Site Inspections
http://www.dnovobio.com Semrush global rank: 8.74 M Semrush visits lastest month: 261
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "dNovo Bio" on Search Engine
dNovo - Home
Founded in 2018, dNovo consists of a team of PhDs and MDs trained at Stanford, Harvard, and Caltech. Together, we are using our backgrounds in reprogramming and …See details»
dNovo Bio - Crunchbase Company Profile & Funding
Dnovobio is a developer of a direct reprogramming technology intended to create any cell, tissue, or organ on demand. Its company's platform converts skin into functional …See details»
dNovo Bio | CipherBio
DNovo Inc. is a pre-clinical cell technology company with a mission to cure baldness by creating new hair de novo. Founded in 2018 by Dr. Ernesto Lujan with initial support …See details»
dNovo Bio - Funding, Financials, Valuation & Investors
Dnovobio is a developer of a direct reprogramming technology intended to create any cell, tissue, or organ on demand.See details»
dNovo Bio | LinkedIn
DNovo Bio | 111 followers on LinkedIn. Towards the Cure for Hair Loss | At dNovo we aim to solve the hair loss problem by making new hair stem cells with our direct …See details»
dNovo Emerges From Stealth With Its Potential Cure …
Jan 24, 2022 Founded in 2018 by Dr. Ernesto Lujan with initial support from Y Combinator, dNovo is developing a direct reprogramming system to convert patient-derived cells into personalized hair stem cells...See details»
dNovo Bio - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Dnovobio is a developer of a direct reprogramming technology intended to create any cell, tissue, or organ on demand.See details»
dNovo Raises $2.7M In Seed Funding - FinSMEs
Jan 24, 2022 dNovo Inc., a San Jose, Calif.-based company developing a cure for hair loss by generating personalized hair stem cells, emerged from stealth with $2.7M in …See details»
dNovo Bio | CipherBio
Explore dNovo Bio's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Denovo Biopharma LLC Announces Breakthrough Discovery of a …
Dec 16, 2021 Denovo Biopharma LLC is a clinical-stage biopharmaceutical company that uses novel biomarker approaches to re-evaluate medicines that have failed in …See details»
Denovo Biopharma LLC Announces FDA Approval of IND to
Jan 31, 2022 Denovo Biopharma LLC is a clinical-stage biopharmaceutical company that uses novel biomarker approaches to executes efficient clinical trials in targeted patient …See details»
dNovo: Biological Reprogramming For Hair Regeneration
Jan 16, 2022 Some of the company’s technological accomplishments include generating human hair stem cells in 2019 and generating human dermal papilla cells in 2021, both …See details»
dNovo Bio - Recent News & Activity - Crunchbase
Jan 24, 2022 Dnovobio is a developer of a direct reprogramming technology intended to create any cell, tissue, or organ on demand.See details»
Denovo Biopharma Creates Innovative Gene Registry Program to …
Mar 6, 2023 Using a unique machine learning technology combined with a whole genome sequencing to identify biomarkers Denovo discovered a novel genetic biomarker that …See details»
Denovo Biopharma
Denovo Biopharma is a clinical-stage biopharmaceutical company focused on the development of biomarker-driven precision medicines. Our technology platform can be …See details»
Denovo Biopharma
Home; Team. Management; Advisors; Pipeline; Media. News; Publications; Careers. Opportunities; Core Values; About. Global Reach; Science; Contact UsSee details»
Biotechnology Innovation Organization | BIO
Biotechnology Innovation Organization | BIO. Thrive with BIO. Members enjoy exclusive opportunities - from advocating for policies that spur innovation to receiving discounts on …See details»
BIO to announce reorganization, senior leaders expected to …
15 hours ago BIO lays off 30 employees, including senior leaders. BIO is proceeding with a restructuring after its new CEO took over. Lane Turner/The Boston Globe. W …See details»
Denovo Biopharma - Crunchbase Company Profile & Funding
Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development. San Diego, California, United States. 11-50. Series D. …See details»
Denovo Biopharma | CipherBio
A Novel Biomarker Discovery Solution for Personalized Drug Development Denovo Biopharma is a private San Diego based biotech company, also operating in China, …See details»